Related Experiment Video
Updated: May 22, 2026
10:28
Biological Compatibility Profile on Biomaterials for Bone Regeneration
Published on: November 16, 2018
Analysis of bone formation after sinus augmentation using β-tricalcium phosphate
Ulrike Schulze-Späte1, Thomas Dietrich, Rayyan A Kayal
1Division of Periodontics, Section of Oral and Diagnostic Sciences, College of Dental Medicine, Columbia University, New York, New York, USA.
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)
|May 24, 2012
Summary
Beta-tricalcium phosphate effectively augments maxillary sinus bone for dental implants. This bone graft material showed good bone development and no inflammatory reactions, leading to successful implant integration.
Area of Science:
- Oral and Maxillofacial Surgery
- Biomaterials Science
- Regenerative Medicine
Background:
- Maxillary sinus augmentation is crucial for dental implant placement in cases of bone height deficiency.
- Beta-tricalcium phosphate (β-TCP) is a synthetic bone graft material with osteoconductive properties.
- Evaluating β-TCP's efficacy in maxillary sinus augmentation is essential for predictable clinical outcomes.
Purpose of the Study:
- To assess the bone development and maturation process in the maxillary sinus after augmentation with beta-tricalcium phosphate.
- To evaluate the biocompatibility and osteogenic potential of beta-tricalcium phosphate in human subjects.
- To determine the long-term success of dental implants placed in conjunction with beta-tricalcium phosphate sinus augmentation.
Main Methods:
- A case series involving maxillary sinus augmentation using beta-tricalcium phosphate.
- Bone biopsies were collected between 21 and 40 weeks post-augmentation for histological analysis.
- Staining techniques including Hematoxylin and Eosin (H&E), Goldner's, and tartrate-resistant acid phosphatase (TRAP) were employed.
- Dental implants were placed simultaneously with bone biopsy and followed for 12 months.
Main Results:
- Histological analysis revealed an increase in total bone volume over time with a corresponding decrease in beta-tricalcium phosphate particles.
- No significant inflammatory reactions were observed around the graft material.
- TRAP staining indicated the presence of osteoclasts actively resorbing the remaining graft particles.
- All placed implants demonstrated successful osseointegration and stability over the 12-month follow-up period.
Conclusions:
- Beta-tricalcium phosphate serves as an effective bone graft material for maxillary sinus augmentation, promoting bone formation and integration.
- The material exhibits excellent biocompatibility, with minimal inflammatory response and evidence of osteoclast-mediated remodeling.
- Successful dental implant outcomes can be achieved following sinus augmentation with beta-tricalcium phosphate, highlighting its clinical utility.
